739029.fig.005a
(a) The overall relapse comparison
739029.fig.005b
(b) The relapse rate of naïve CHC patients treated with the two types of peginterferons
739029.fig.005c
(c) The relapse rate of CHC patients with HCV genotype 1 or 4 treated with the two types of peginterferons
Figure 5: The relapse rate of CHC patients who received the two regimens.